--- a
+++ b/clusters/9knumclustersv2/clust_1304.txt
@@ -0,0 +1,161 @@
+Bilirubin less than . mg/dL (except for patients with Gilberts Syndrome of indirect hyperbilirubinemia)
+ELIGIBILITY CRITERIA FOR RANDOMIZATION (STEP ): Bilirubin =< . x ULN (except in patients with documented Gilberts disease, who must have a total bilirubin =< . mg/dL)
+Total bilirubin (=< . mg/dl) normal unless history of Gilberts syndrome
+Total bilirubin =< . mg/dL; in patients with Gilberts syndrome, total bilirubin >= . is permitted
+Total bilirubin =< . x ULN (except in patients with Gilberts syndrome who may have total bilirubin < . mg/dL)
+Total bilirubin =< . mg/dL (=< . in patients with known Gilberts syndrome)
+Total bilirubin =< . mg/dl, except in subjects with Gilberts syndrome
+Total bilirubin =< . mg/dL or <  mg/dL if attributable to hepatic infiltration by neoplastic disease or Gilberts syndrome
+Total bilirubin =< . mg/dL unless related to Gilberts disease or patients lymphoma
+Total bilirubin =< . mg/dL (=< . in participants with known Gilberts syndrome)
+Total bilirubin =< . mg/dl unless due to underlying conjugation disease such as Gilberts
+Bilirubin =< . x ULN, (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin less than or equal to  mg/dl, except in patients with Gilberts syndrome, who must have a total bilirubin less than or equal to  mg/dl
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin less than or equal to  mg/dl, except in patients with Gilberts syndrome, who must have a total bilirubin less than or equal to  mg/dl
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome, who must have a total bilirubin =< . mg/dl.
+Total bilirubin within normal institutional limits; for patients with Gilberts syndrome, total bilirubin =< . mg/dL.
+Total bilirubin within normal institutional limits; in patients with Gilberts, ? . mg/dL
+Total bilirubin =< . mg/dl, except in patients with Gilberts Syndrome, who must have a total bilirubin < . mg/dl
+Total bilirubin less than or equal to  mg/dl, except in patients with Gilberts syndrome, who must have a total bilirubin less than or equal to  mg/dl
+COHORT : HORMONE RECEPTOR POSITIVE BREAST CANCER: Total bilirubin < . X ULN, unless known diagnosis of Gilberts syndrome, where bilirubin =<  mg/dL will be permitted; Gilberts syndrome will be defined as elevated unconjugated bilirubin, with conjugated (direct) bilirubin within the normal range and less than % of the total; total bilirubin will be permitted up to  mg/dL, if patients have historical readings consistent with the definition of Gilberts syndrome prior to entering study
+COHORT : TRIPLE NEGATIVE BREAST CANCER: Total bilirubin < . X ULN, unless known diagnosis of Gilberts syndrome, where bilirubin =<  mg/dL will be permitted; Gilberts syndrome will be defined as elevated unconjugated bilirubin, with conjugated (direct) bilirubin within the normal range and less than % of the total; total bilirubin will be permitted up to  mg/dL, if patients have historical readings consistent with the definition of Gilberts syndrome prior to entering study
+COHORT : ENDOMETRIAL CANCER: Total bilirubin < . X ULN, unless known diagnosis of Gilberts syndrome, where bilirubin =<  mg/dl will be permitted; Gilberts syndrome will be defined as elevated unconjugated bilirubin, with conjugated (direct) bilirubin within the normal range and less than % of the total; total bilirubin will be permitted up to  mg/dL, if patients have historical readings consistent with the definition of Gilberts syndrome prior to entering study
+Direct bilirubin =< . mg/dL in the absence of suspected Gilberts disease (if Gilberts disease is suspected, the total bilirubin must be =< . mg/dL)
+Bilirubin =< . mg/dL (OR in patients with Gilberts syndrome, a total bilirubin =< .) (within  days before starting therapy)
+Total bilirubin =< . mg/dL, except in patients with Gilberts syndrome, who must have a total bilirubin =< . mg/dL
+Total bilirubin =<  mg/dL; for subjects with known Gilberts disease, bilirubin =< . mg/dL
+Total bilirubin < . g/dl OR < . g/dl if Gilberts syndrome or disease infiltration of the liver is present
+Total bilirubin =< . mg/dl, except in subjects with Gilberts syndrome
+REP ELIGIBILITY: Total bilirubin less than or equal to . mg/dL, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dL
+CHEMOTHERAPY/CELL INFUSION ELIGIBILITY: Total bilirubin less than or equal to . mg/dL, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dL
+Total bilirubin within normal institutional limits except in patients with Gilberts syndrome who must have a total bilirubin < . mg/dL
+Total bilirubin =< to . mg/dL, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dL
+Total bilirubin (except patients with Gilberts Syndrome, who are eligible for the study but exempt from the total bilirubin eligibility criterion) =< . mg/dl within  days prior to Step  registration and
+Bilirubin =< . mg/dL (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL) obtained <  weeks prior to starting treatment
+Total bilirubin =< . mg/dL, except in subjects with Gilberts Syndrome in whom total bilirubin must be =< . mg/dL
+Total bilirubin < . mg/dl-exception permitted in patients with Gilberts syndrome
+Total bilirubin < . X ULN, unless known diagnosis of Gilberts syndrome, where bilirubin =<  mg/dl will be permitted; Gilberts syndrome will be defined as elevated unconjugated bilirubin, with conjugated (direct) bilirubin within the normal range and less than % of the total; total bilirubin will be permitted up to  mg/dl, if patients have historical readings consistent with the definition of Gilberts syndrome prior to entering study
+Total bilirubin =< . mg/dL unless due to known Gilberts disease obtained =<  days prior to registration\r\n* NOTE: If total bilirubin is >  mg/dL, a direct bilirubin should be performed and must be < . mg/dL for Gilberts to be diagnosed
+Total bilirubin =< . mg/dL, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dL
+Total bilirubin less than or equal to  mg/dL (>  mg/dL permitted if the patient has evidence of Gilberts disease based upon prior bilirubin elevation or genetic testing)
+Total bilirubin =< to . mg/dL, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dL
+Bilirubin =<  x ULN (except subjects with Gilberts syndrome, who must have total bilirubin < . mg/dL)
+Bilirubin =< . mg/dL (excluding Gilberts syndrome)
+Total bilirubin =< . mg/dL, unless hyperbilirubinemia is attributable solely to Gilberts syndrome
+Total bilirubin =< to . mg/dl, except in patients with Gilberts Syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< . x ULN, except subjects with Gilberts syndrome or liver metastases, who must have a baseline total bilirubin =< . mg/dL
+Bilirubin < . mg/dL (except for Gilberts syndrome which will allow bilirubin =< . mg/dL)
+Total bilirubin =< . mg/dL (unless previously diagnosed with Gilberts syndrome)
+Bilirubin less than or equal to . mg/dl (unless due to Gilberts syndrome)
+Obtained =<  days prior to registration: Total bilirubin =< . mg/dL or direct bilirubin =< . mg/dL for patients with Gilberts syndrome
+Total bilirubin =< . x ULN except in patients with documented Gilberts syndrome or liver metastasis, who must have a baseline total bilirubin =< . mg/dl
+Bilirubin < . mg/dl, unless subject has Gilberts syndrome (=< . mg/dL)
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< . mg/dl (except for patients in whom hyperbilirubinemia is attributed to Gilberts syndrome)
+Bilirubin < . mg/dL, with the exception of patients thought to have Gilberts syndrome, who may have a total bilirubin above . mg/dL
+Total bilirubin =< . mg% (unless from Gilberts disease or disease-related)
+Total bilirubin =< . mg/dL; (does NOT apply to patients with Gilberts syndrome)
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< . mg/dL (=< . mg/dL for patients with known Gilberts syndrome), unless these are thought to be due to AML
+Total serum bilirubin =< . mg/dl (patients with total bilirubin > . mg/dL eligible only with Gilberts syndrome)
+Bilirubin < . mg/dL, unless subject has Gilberts Syndrome (=< . mg/dL)
+Bilirubin =< . x ULN, (except patients with Gilberts Syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl (Turnstile II)
+Bilirubin equal or less than . mg/dl except for Gilberts disease
+Total or direct bilirubin =< . mg/dL (if not due to the leukemia itself or known Gilberts syndrome) (as documented by treating physician)
+Total bilirubin < . mg/dl, unless a diagnosis of Gilberts disease
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl (Turnstile II)
+Bilirubin =< . x ULN, (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin =< . mg/dl, except in patients with Gilberts syndrome, who must have a total bilirubin =< . mg/dl
+Bilirubin < . mg/dL with the exception of patients thought to have Gilberts syndrome, who may have a total bilirubin above . mg/dL
+Total bilirubin =< . mg/dL or direct bilirubin =< . mg/dL for patients with Gilberts syndrome
+Total bilirubin must be less than  mg/dl (unless due to CLL involvement of liver or a known history of Gilberts disease)
+Total bilirubin =< . mg/dL, except in subjects with Gilberts syndrome in whom total bilirubin must be =< . mg/dL
+Total bilirubin =< . mg/dL, except in subjects with Gilberts syndrome in whom total bilirubin must be =< . mg/dL.
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin </= . x ULN except in patients with documented Gilberts syndrome or liver metastasis, who must have a baseline total bilirubin . mg/dl within  weeks prior to initial treatment
+Total serum bilirubin > . x ULN (patients with Gilberts disease may be included if their total bilirubin is =< . mg/dL).
+Total bilirubin >  mg/dL (in the absence of Gilberts disease)
+Total bilirubin < .mg/dL unless due to Gilberts disease
+Total bilirubin within =< . normal institutional limits (patients with Gilberts syndrome with total bilirubin up to . mg/dL is allowed)
+Serum bilirubin =< . x ULN, (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Bilirubin =< . mg/dL (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< . mg% (unless from Gilberts disease or disease-related)
+Total bilirubin less than or equal to . mg/dL, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dL
+Bilirubin =<  x ULN (except subjects with Gilberts syndrome, who must have total bilirubin < . mg/dL)
+Total bilirubin must be =< . mg/dL except in patients with Gilberts syndrome (as defined by > % unconjugated bilirubin) it must be <  mg/dl
+Serum bilirubin =< . x ULN (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Bilirubin >  mg/dl (total) except >  mg/dl in patients with Gilberts syndrome as defined by > % unconjugated
+Serum bilirubin < . mg/dL unless Gilberts disease
+Bilirubin =<  x ULN (except subjects with Gilberts syndrome, who must have total bilirubin < . mg/dL)
+Bilirubin =< . x ULN (except for patients with Gilberts syndrome, who must have a total bilirubin =<  mg/dL)
+Total bilirubin (except patients with Gilberts syndrome, who are eligible for the study but exempt from the total bilirubin eligibility criterion) =< . mg/dl
+Bilirubin < . mg/dl, unless subject has Gilberts syndrome (=< . mg/dL)
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< . mg/dl (unless the patient has a history of Gilberts syndrome)
+Total bilirubin =< . mg/dL (<  mg/dL for patients with Gilberts syndrome)
+Total serum bilirubin =< .  the ULN; for subjects with known Gilberts disease or similar syndrome with slow conjugation of bilirubin, total bilirubin =< . mg/dL
+Total bilirubin =< . mg/dL, unless due to Gilberts disease
+Bilirubin =< . mg/dL (OR in patients with Gilberts syndrome, a total bilirubin =< .) (within  days before starting therapy)
+Total bilirubin =< .. mg/dL or < . mg/dL if attributable to hepatic infiltration by neoplastic disease or Gilberts syndrome
+In the case of Gilberts syndrome, or documented liver or pancreatic involvement by lymphoma, the requirement for total bilirubin is =< . mg/dL
+Total bilirubin =< . x ULN; for participants with Gilberts disease =< . mg/dL
+Total bilirubin < . mg/dl-exception permitted in patients with Gilberts syndrome
+Total bilirubin =< . mg/dl-exception permitted in participants with Gilberts syndrome
+Bilirubin =< . mg/dl within  days prior to study registration unless patient has Gilberts syndrome
+Total bilirubin =< . mg/dL (exception: patients with documented Gilberts syndrome are allowed to participate despite elevated bilirubin)
+Bilirubin < . mg/dl (OR in patients with Gilberts syndrome, a total bilirubin =< . mg/dL)
+Bilirubin =< . x ULN (except for patients with Gilberts syndrome, who must have a total bilirubin =<  mg/dL)
+Serum total bilirubin =< . mg/dL; Note, patients with Gilberts syndrome may have elevated bilirubin at baseline prior to diagnosis with AML or MDS; patients with Gilberts syndrome are included if their total bilirubin is =<  times their baseline total bilirubin
+Serum total bilirubin > . mg/dL; Note, patients with Gilberts syndrome may have elevated bilirubin at baseline prior to diagnosis with AML or MDS; patients with Gilberts syndrome are excluded if their total bilirubin is >  times their baseline total bilirubin
+Total bilirubin =< . x ULN, except subjects with Gilberts syndrome who can have total bilirubin =< . mg/dL
+Total bilirubin =< . mg/dl, except in cases of Gilberts disease
+Total bilirubin <  X ULN (except for subjects with documented Gilberts syndrome who can have total bilirubin < . mg/dl)
+Bilirubin =< . ULN, (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin =< . mg/dL (unless MCL related or attributable to Gilberts disease)
+Bilirubin =< . x ULN, (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Bilirubin =< . x ULN, (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Bilirubin: ~ . x ULN (except for subjects with Gilberts syndrome, who must have a total bilirubin of less than . mg/dL)
+Total bilirubin < . mg/dL (unless documented Gilberts syndrome)
+Total bilirubin < . mg/dl except <  mg/dL in patients with Gilberts (as defined as > % unconjugated hyperbilirubinemia without other known cause); unless impairment due to organ involvement by lymphoma
+Serum bilirubin >  mg/dl (unless due to Gilberts syndrome)
+Total bilirubin =<  X ULN, except for patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl (part  & )
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Bilirubin =< . mg/dl (total) except <  mg/dl in patients with Gilberts syndrome as defined by > % unconjugated
+Total bilirubin =< . mg/dL (except patients with Gilberts syndrome)
+Bilirubin: =< . x ULN (except for subjects with Gilberts syndrome, who must have a total bilirubin of less than . mg/dL)
+Serum bilirubin levels =< . mg/dL except for patients with Gilberts syndrome
+Bilirubin for Gilberts =< . mg/dl
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Bilirubin < . mg/dl except for Gilberts disease
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Bilirubin =< . ULN, (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin < . mg/dL, except when the patient is known to have Gilberts syndrome, the total bilirubin can be =< . mg/dL
+Total bilirubin =< to . mg/dL, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dL
+Serum bilirubin levels =< . mg/dL except for patients with Gilberts syndrome
+Total bilirubin =< . mg/dL (excluding Gilberts syndrome), unless due to lymphoma
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin less than or equal to  mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than  mg/dl
+Total bilirubin less than or equal to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Total bilirubin =< to . mg/dl, except in patients with Gilberts syndrome who must have a total bilirubin less than . mg/dl
+Bilirubin =< . x ULN, (except patients with Gilberts syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin =< . mg/dL unless due to Gilberts disease
+Total bilirubin < . mg/dL unless the increase in bilirubin is attributable to Gilberts syndrome
+Bilirubin =< . x ULN (except subjects with Gilberts syndrome who must have total bilirubin =< . mg/dL), obtained within  days of the first dose of study drug
+Total serum bilirubin =< . mg/dl (patients with total bilirubin > . mg/dL eligible only with Gilberts syndrome)
+Total bilirubin < . mg/dl-exception permitted in participants with Gilberts syndrome
+A bilirubin of up to . mg/dL, excluding patients with Gilberts disease
+Bilirubin =< . mg/dL (or =< . mg/dL for patients with Gilberts syndrome)
+Total bilirubin =< . mg/dl (unless the patient has a history of Gilberts syndrome)
+Total bilirubin >=  x the upper limits of normal or > . mg/dl in patients with Gilberts syndrome
+Total bilirubin <  x normal institutional limits or > . mg/dl in patients with Gilberts syndrome